Brings extensive small molecule drug discovery, development, and clinical experience across multiple therapeutic areas Will drive application of Outrun's novel, proprietary X-E3L platform for protein stabiliser discovery to develop a pipeline of high-quality drug candidates targeting E3...
Read More Details
Finally We wish PressBee provided you with enough information of ( Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer )
Also on site :
- What to Know About the Investigation Into Influencer Gloria Zamora’s Death
- Deaths reported during protests in Kenya (VIDEO)
- Indian refineries ramp up Russian crude purchases – Bloomberg